32
Participants
Start Date
November 30, 2002
Study Completion Date
April 30, 2004
INSULIN GLARGINE
The subjects will continue the treatment with HOE 901 in the same way as they have done in the previous study. Based on the investigator's assessment and the approved SPC in Belgium/Luxembourg, the dosage can be adjusted individually. HOE 901 is to be injected once daily. HOE 901 must not be mixed with any other insulin, including regular human insulin or fast-acting insulin analogues.
Sanofi-Aventis, Brussels
Lead Sponsor
Sanofi
INDUSTRY